You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Obinutuzumab

Showing 201 - 225 of 229
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Chronic Lymphocytic Leukemia (CLL), Small Lymphocytic Lymphoma Trial in Boston (Venetoclax, Zanubrutinib)

Recruiting
  • Chronic Lymphocytic Leukemia (CLL)
  • Small Lymphocytic Lymphoma
  • Boston, Massachusetts
  • +2 more
Mar 16, 2022

Non-Hodgkin's Lymphoma Trial in Worldwide (Obinutuzumab, Bendamustine)

Completed
Has Results
  • Non-Hodgkin's Lymphoma
  • Mobile, Alabama
  • +120 more
Dec 20, 2019

Cancer Target Therapy Efficacy

Active, not recruiting
  • Cancer
  • RNA sequencing
  • +5 more
  • Walnut, California
  • +6 more
Sep 13, 2021

Chronic Lymphocytic Leukemia Trial in Worldwide (Bendamustine, Chlorambucil, Cyclophosphamide)

Completed
Has Results
  • Chronic Lymphocytic Leukemia
  • Santa Fé, Argentina
  • +173 more
Oct 24, 2019

DLBCL Trial in Chicago (drug, biological, other)

Terminated
Has Results
  • Diffuse Large B-Cell Lymphoma
  • Bendamustine Hydrochloride
  • +4 more
  • Chicago, Illinois
    University of Chicago Comprehensive Cancer Center
May 7, 2018

Chronic Lymphocytic Leukemia Trial in La Jolla (Lenalidomide, Obinutuzumab)

Withdrawn
  • Chronic Lymphocytic Leukemia
  • La Jolla, California
    UC San Diego Moores Cancer Center
Feb 21, 2018

Repeat Immunoadsorption Post Covid ME/CFS

Recruiting
  • Post-COVID ME/CFS
  • IA with TheraSorb ® column
  • Berlin, Germany
    Charité - Universitätsmedizin Berlin
Nov 21, 2022

Chronic Lymphocytic Leucemia Trial in Cologne (GA101 (Obinutuzumab), Bendamustine)

Active, not recruiting
  • Chronic Lymphocytic Leucemia
  • Cologne, Germany
    German CLL Study Group
Aug 10, 2018

Expression of CD19 Complex in Lymphoproliferative Disorders

Not yet recruiting
  • Lymphoproliferative Disorders
  • Flow cytometry
  • (no location specified)
Feb 2, 2021

DLBCL Trial in Worldwide (Rituximab, Obinutuzumab, Cyclophosphamide)

Terminated
Has Results
  • Diffuse Large B-Cell Lymphoma
  • Birmingham, Alabama
  • +234 more
Apr 8, 2019

Lymphoma, Non-Hodgkin Trial in Duarte, Nashville (Atezolizumab, Emactuzumab, Obinutuzumab)

Withdrawn
  • Lymphoma, Non-Hodgkin
  • Duarte, California
  • +1 more
Apr 3, 2018

Lymphoma, B-Cell Trial in United States (obinutuzumab, cyclophosphamide, doxorubicin)

Completed
Has Results
  • Lymphoma, B-Cell
  • obinutuzumab
  • +4 more
  • Birmingham, Alabama
  • +37 more
Apr 24, 2018

Early-progressed Follicular Lymphoma in Korea

Unknown status
  • Follicular Lymphoma
    • Seoul, Korea, Republic of
      81, Irwon-ro, Gangnam-gu, Seoul, Republic of Korea
    Aug 5, 2019

    Lymphocytic Leukemia, Chronic Trial in Worldwide (obinutuzumab, rituximab, chlorambucil)

    Completed
    Has Results
    • Lymphocytic Leukemia, Chronic
    • obinutuzumab
    • +2 more
    • San Diego, California
    • +261 more
    Aug 15, 2018

    Lymphocytic Leukemia, Chronic Trial in Worldwide (obinutuzumab, rituximab, chlorambucil)

    Completed
    Has Results
    • Lymphocytic Leukemia, Chronic
    • obinutuzumab
    • +2 more
    • San Diego, California
    • +261 more
    Aug 15, 2018

    Chronic Lymphocytic Leukemia Trial in Brno, Hradec Králové

    Unknown status
    • Chronic Lymphocytic Leukemia
      • Brno, Czechia
      • +1 more
      Mar 15, 2019

      Post-transplant Lymphoproliferative Disorder, PTLD Trial (Obinutuzumab)

      Withdrawn
      • Post-transplant Lymphoproliferative Disorder
      • PTLD
      • Obinutuzumab
      • (no location specified)
      Mar 16, 2017

      Lymphocytic Leukemia, Chronic Trial in Worldwide (obinutuzumab, rituximab, chlorambucil)

      Completed
      Has Results
      • Lymphocytic Leukemia, Chronic
      • obinutuzumab
      • +2 more
      • San Diego, California
      • +261 more
      Aug 15, 2018

      Chronic Lymphocytic Leukemia Trial in United States (Obinutuzumab, Chlorambucil)

      Completed
      Has Results
      • Chronic Lymphocytic Leukemia
      • Huntsville, Alabama
      • +18 more
      Mar 20, 2017

      Lymphoma, B-Cell Trial in Italy (Obinutuzumab, Ibrutinib, CHOP)

      Terminated
      • Lymphoma, B-Cell
      • Obinutuzumab
      • +2 more
      • Candiolo, TO, Italy
      • +28 more
      Mar 16, 2017

      Lymphocytic Leukemia, Chronic Trial in United States (Fludarabine, Obinutuzumab, Bendamustine)

      Completed
      Has Results
      • Lymphocytic Leukemia, Chronic
      • Huntsville, Alabama
      • +17 more
      Dec 8, 2016

      Indolent Non-Hodgkin's Lymphoma Trial in United States (Arm A: Rituximab, Arm B: GA101)

      Terminated
      Has Results
      • Indolent Non-Hodgkin's Lymphoma
      • Arm A: Rituximab
      • Arm B: GA101
      • Mobile, Alabama
      • +27 more
      Mar 23, 2017

      Lymphocytic Leukemia, Chronic Trial in United States (Obinutuzumab, Corticosteroids)

      Completed
      Has Results
      • Lymphocytic Leukemia, Chronic
      • Birmingham, Alabama
      • +30 more
      Mar 20, 2017

      Optimizing HBV Management During Anti-CD20 Antibodies

      Completed
      • Liver Dysfunction
      • +2 more
      • Anti-CD20 antibody
      • Hong Kong, Hong Kong
        The University of Hong Kong
      May 1, 2018

      Lymphoma Trial in France, Germany (Obinutuzumab)

      Completed
      Has Results
      • Lymphoma
      • Obinutuzumab
      • Creteil, France
      • +15 more
      Aug 18, 2016